Exclusive: Virbac’s New CEO on Investment, Innovation & Long-Term Growth Strategy

What does new leadership at a top 10 animal health company signal for the future of the industry?  In this exclusive interview, Virbac’s new CEO Paul Martingell joins Animal Health Insider for his first in-depth industry conversation since stepping into the role.  Paul shares his early impressions of animal health, what he learned from leading through transformation, and how those experiences are helping to guide Virbac’s next chapter. From R&D investment and long-term growth strategy to innovation, manufacturing, and culture, this conversation explores what it takes to compete and win in today’s evolving animal health landscape.  We also discuss:  📈 Virbac’s growth ambitions and 2030 profitability targets  💰 Investing through uncertainty and why R&D matters now more than ever  🐾 Breakthrough innovation  🐄 Underutilized opportunities in livestock  🌍 Sustainability, One Health, and where the industry is headed next  If you are watching leadership transitions closely, thinking about capital allocation, or evaluating where animal health innovation is going, this is one you will not want to miss.  #AnimalHealth #Veterinary #Virbac #Biotech #Leadership   About Animal Health Insider  Animal Health Insider takes you behind the scenes of the Animal Health industry. Each episode starts with conversation from the “Insiders,” followed by in-depth conversations with the leaders and disruptors shaping what’s next.  If you work in #AnimalHealth, #Veterinary, #Biotech, #Agtech, #Sustainability, #Investment, or #PublicPolicy, subscribe for sharper context and real insight from the people on the inside of the industry.  🌐 Learn more at https://www.lawlesscomms.com/podcast/  LawlessComms  Ready to build industry influence and engage employees through strategic communications made for Animal Health? We’re here to help.  🌐 https://www.lawlesscomms.com/  LinkedIn: https://www.linkedin.com/in/julielawless  Stonehaven Transactions  With decades of commercial and legal experience in M&A and other transactions in the animal health sector, Stonehaven Transactions guides small and large life science companies and investors through buy-side or sell-side transactions, license deals and commercial collaborations, ensuring value maximization, a seamless process, optimized synergies, and long-term growth.  🌐 https://sc.group/transactions/  LinkedIn: https://www.linkedin.com/in/dr-beatrice-vos-4184201  S&P Global Animal Health  Beyond the headlines, S&P Global Animal Health provides expert insights for your animal health business.  🌐 https://www.spglobal.com/commodity-insights/en/industries/agriculture/animal-health  LinkedIn: https://www.linkedin.com/in/joseph-harvey-08109916